These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1426419)
1. IL-1 and pro-inflammatory cytokines produced by primary and transformed fibroblasts abrogate the tumorigenic potential of fibrosarcomas. Apte RN; Douvdevani A; Huleihel M; Fima E; Hacham M; Shimoni N; Dvorkin T; Segal S Folia Biol (Praha); 1992; 38(3-4):240-57. PubMed ID: 1426419 [TBL] [Abstract][Full Text] [Related]
2. Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications. Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Huleihel M; Fima E; Hacham M; Voronov E Folia Biol (Praha); 1994; 40(1-2):1-18. PubMed ID: 7958060 [TBL] [Abstract][Full Text] [Related]
3. Regulation of interleukin 1 generation in immune-activated fibroblasts. Huleihel M; Douvdevani A; Segal S; Apte RN Eur J Immunol; 1990 Apr; 20(4):731-8. PubMed ID: 2189735 [TBL] [Abstract][Full Text] [Related]
4. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential. Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788 [TBL] [Abstract][Full Text] [Related]
5. Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha. Dvorkin T; Song X; Argov S; White RM; Zoller M; Segal S; Dinarello CA; Voronov E; Apte RN J Leukoc Biol; 2006 Jul; 80(1):96-106. PubMed ID: 16707560 [TBL] [Abstract][Full Text] [Related]
6. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity. Douvdevani A; Huleihel M; Segal S; Apte RN Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231 [TBL] [Abstract][Full Text] [Related]
7. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression. Voronov E; Weinstein Y; Benharroch D; Cagnano E; Ofir R; Dobkin M; White RM; Zoller M; Barak V; Segal S; Apte RN Cancer Res; 1999 Mar; 59(5):1029-35. PubMed ID: 10070959 [TBL] [Abstract][Full Text] [Related]
8. Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer. Douvdevani A; Huleihel M; Zöller M; Segal S; Apte RN Int J Cancer; 1992 Jul; 51(5):822-30. PubMed ID: 1612788 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of cytokine production by fibroblasts-implications for normal connective tissue homeostasis and pathological conditions. Apte RN Folia Microbiol (Praha); 1995; 40(4):392-404. PubMed ID: 8763153 [TBL] [Abstract][Full Text] [Related]
11. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells. Yoshizawa H; Chang AE; Shu SY Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321 [TBL] [Abstract][Full Text] [Related]
12. Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells. Callahan GN J Immunol; 1984 May; 132(5):2649-57. PubMed ID: 6201554 [TBL] [Abstract][Full Text] [Related]
13. Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicity. Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Fima E; Hacham M; Huleihel M; Benharroch D Immunol Lett; 1993 Dec; 39(1):45-52. PubMed ID: 8144190 [TBL] [Abstract][Full Text] [Related]
14. Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity. Chou T; Chang AE; Shu SY J Immunol; 1988 Apr; 140(7):2453-61. PubMed ID: 2450925 [TBL] [Abstract][Full Text] [Related]
15. Ethanol suppression of the hypothalamic proopiomelanocortin level and the splenic NK cell cytolytic activity is associated with a reduction in the expression of proinflammatory cytokines but not anti-inflammatory cytokines in neuroendocrine and immune cells. Chen CP; Boyadjieva NI; Advis JP; Sarkar DK Alcohol Clin Exp Res; 2006 Nov; 30(11):1925-32. PubMed ID: 17067358 [TBL] [Abstract][Full Text] [Related]
16. The induction of IL-6 and gelatinase B by IL-1 in mouse cell lines transformed with bovine papillomavirus: decreased production in tumorigenic cells. Fuse A; Simizu B; Van Ranst M; Opdenakker G; Van Damme J Lymphokine Cytokine Res; 1992 Aug; 11(4):215-20. PubMed ID: 1330001 [TBL] [Abstract][Full Text] [Related]
17. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes. Matsumura T; Sussman JJ; Krinock RA; Chang AE; Shu S Cancer Res; 1994 May; 54(10):2744-50. PubMed ID: 8168105 [TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction. Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794 [TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses towards a type 1 pattern. Li Q; Carr AL; Donald EJ; Skitzki JJ; Okuyama R; Stoolman LM; Chang AE Cancer Res; 2005 Feb; 65(3):1063-70. PubMed ID: 15705908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]